Exploratory study on inflammatory immune response related to endothelial dysfunction in HIV-infected naive patients treated with abacavir compared to tenofovir-based regimens.

Trial Profile

Exploratory study on inflammatory immune response related to endothelial dysfunction in HIV-infected naive patients treated with abacavir compared to tenofovir-based regimens.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2015

At a glance

  • Drugs Abacavir (Primary) ; Efavirenz (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms ABRACADABRA
  • Most Recent Events

    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top